Breath Alcohol Intervention for Alcohol Use Disorder

(BAMTECH Trial)

Overseen By Allie Farone, M.S.

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Northeastern University

Disqualifiers: Severe substance use disorder, psychotic, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

Duration: 4 weeks

90 Participants Needed

Trial Summary

What is the purpose of this trial?

This is the third stage of a three-stage, NIH-funded study to develop and test a multi-modal intervention concerning blood/breath alcohol concentration for young adults who drink heavily. The multimodal intervention will be made up of brief telehealth counseling and psychoeducation and use of three existing mobile technologies. The brief counseling/psychoeducation and mobile technologies provide personalized feedback regarding blood or breath alcohol content. The long-term goal of use of these mobile technologies will be to facilitate moderate drinking. However, the main goals of the proposed research are to learn more about feasibility of our procedures, perceived value of the technologies and ease of use from the research participants' points of view. In this third stage of the study, the investigators will conduct a randomized controlled trial building on the formative research conducted in Stages 1 and 2.

Research Team

Robert F Leeman, Ph.D.

Principal Investigator

Northeastern University

Eligibility Criteria

This trial is for young adults who drink heavily and are interested in moderating their alcohol consumption. Participants should be willing to engage with telehealth counseling, psychoeducation, and use mobile technologies that provide feedback on their alcohol levels.

Inclusion Criteria

Be able to read English and complete study evaluations

At least occasional heavy episodic drinking (i.e., 4 or more drinks for women and 5 or more drinks for men) over the prior 30 days

Frequent consumption of at least one alcoholic drink during a minimum of 12 days out of the prior 30 so that subjects will have multiple opportunities to use the moderate drinking technologies during the intervention period.

Exclusion Criteria

Be psychotic or otherwise severely psychiatrically disabled

Severe substance use disorder

I have a health condition that prevents me from drinking alcohol.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive brief telehealth counseling and psychoeducation, and use three mobile technologies for personalized feedback on blood or breath alcohol content

4 weeks

Telehealth sessions and mobile app usage

Follow-up

Participants are monitored for feasibility, perceived value, and ease of use of the technologies

4 weeks

Treatment Details

Interventions

• Multi-Component Breath Alcohol Intervention

Trial Overview The study tests a multi-modal intervention combining brief telehealth counseling/psychoeducation with three mobile technologies aimed at providing personalized feedback on blood or breath alcohol content to promote moderate drinking habits.

Participant Groups

Group I: Moderate drinking technologies with "lower tech" facilitation Experimental Treatment 3 Interventions

Brief motivational-interviewing-based counseling followed by use of three moderate drinking technologies (breath alcohol device and app, blood alcohol content estimator app and self-texting procedure) with "lower tech" facilitation.

Group II: Moderate drinking technologies with "higher tech" facilitation Experimental Treatment 3 Interventions

Brief motivational-interviewing-based counseling followed by use of three moderate drinking technologies (breath alcohol device and app, blood alcohol content estimator app and self-texting procedure) with "higher tech" facilitation

Group III: Alcohol Education Condition Active Control 2 Interventions

Brief session administering non-personalized information about alcohol followed by the option to receive educational alcohol-related information via text

Who Is Running the Clinical Trial?

Northeastern University

Lead Sponsor

Trials

103

Recruited

72,600+

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator

Trials

865

Recruited

1,091,000+